2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation

Atrial fibrillation (AF) is the most common sustained arrhythmia, causing a 2‐fold increase in mortality and a 5‐fold increase in stroke. The Asian population is rapidly aging, and in 2050, the estimated population with AF will reach 72 million, of whom 2.9 million may suffer from AF‐associated stro...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Journal of arrhythmia Ročník 33; číslo 4; s. 345 - 367
Hlavní autoři: Chiang, Chern‐En, Okumura, Ken, Zhang, Shu, Chao, Tze‐Fan, Siu, Chung‐Wah, Wei Lim, Toon, Saxena, Anil, Takahashi, Yoshihide, Siong Teo, Wee
Médium: Journal Article
Jazyk:angličtina
Vydáno: Japan John Wiley & Sons, Inc 01.08.2017
Elsevier
Wiley
Témata:
Age
Anticoagulants
Anticoagulation
Asian people
Atrial fibrillation
Cardiac arrhythmia
Cardiology
Diabetes
Disease prevention
Females
Guideline
Heart failure
Hypertension
Ischemia
Non-vitamin K antagonist oral anticoagulants
Patients
Risk factors
Stroke
Transient ischemic attack
Vitamin K antagonist
Asia
East Asia
Taiwan
Stroke
Anticoagulation
Vitamin K antagonist
Atrial fibrillation
Non-vitamin K antagonist oral anticoagulants
ISSN:1880-4276, 1883-2148
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Atrial fibrillation (AF) is the most common sustained arrhythmia, causing a 2‐fold increase in mortality and a 5‐fold increase in stroke. The Asian population is rapidly aging, and in 2050, the estimated population with AF will reach 72 million, of whom 2.9 million may suffer from AF‐associated stroke. Therefore, stroke prevention in AF is an urgent issue in Asia. Many innovative advances in the management of AF‐associated stroke have emerged recently, including new scoring systems for predicting stroke and bleeding risks, the development of non‐vitamin K antagonist oral anticoagulants (NOACs), knowledge of their special benefits in Asians, and new techniques. The Asia Pacific Heart Rhythm Society (APHRS) aimed to update the available information, and appointed the Practice Guideline sub‐committee to write a consensus statement regarding stroke prevention in AF. The Practice Guidelines sub‐committee members comprehensively reviewed updated information on stroke prevention in AF, emphasizing data on NOACs from the Asia Pacific region, and summarized them in this 2017 Consensus of the Asia Pacific Heart Rhythm Society on Stroke Prevention in AF. This consensus includes details of the updated recommendations, along with their background and rationale, focusing on data from the Asia Pacific region. We hope this consensus can be a practical tool for cardiologists, neurologists, geriatricians, and general practitioners in this region. We fully realize that there are gaps, unaddressed questions, and many areas of uncertainty and debate in the current knowledge of AF, and the physician׳s decision remains the most important factor in the management of AF.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1880-4276
1883-2148
DOI:10.1016/j.joa.2017.05.004